Skip to content

UNIVERSAL EXERCISE UNIT and REBOUND THERAPY ON GENU RECURVATUM Cerebral Palsy Childeren

EFFECT OF UNIVERSAL EXERCISE UNIT VERSUS REBOUND THERAPY ON GENU RECURVATUM IN CHILDREN WITH SPASTIC CEREBRAL PALSY

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07008521
Enrollment
60
Registered
2025-06-06
Start date
2025-03-01
Completion date
2025-10-01
Last updated
2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genu Recurvatum

Keywords

genu recurvatum, Cerebral Palsy, Universal Exercise Unit, Rebound Therapy

Brief summary

to investigate and compare between effectiveness of Universal Exercise Unit and Rebound Therapy on genu recurvatum, muscle strength, balance, functional mobility and quality of life in spastic cerebral palsy children

Detailed description

Children will be equally assigned into three groups using simple randomization, control group, study group (A) and study group (B). Each group will consist of 20 children with spastic CP to overcome any drop out may occur. Control group: Children in this group will receive a traditional physical therapy program. Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program. Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy. Evaluation will be carried out for each child individually before and after 3 months of treatment.

Interventions

PROCEDUREUniversal exercise unit

universal exercise unit (UEU) for study groip (A)

rebound therpay for study group (B)

PROCEDURETraditional physical therapy program

traditional physical therapy program for contrl group

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be assigned randomly into three groups of equal number (control group, study group A and study group B ) the randomization will be performed by simple randomization. Assessors will be blinded to the groups of the subjects.

Eligibility

Sex/Gender
ALL
Age
5 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* -Children with spastic CP both hemiplegic and diplegic. * Their ages will be ranged from 5-7 years old. * They will have mild spasticity (grade 1 and 1+) according to Modified Ashworth scale . * They will be in level I and II according to gross motor function classification system (GMFCS) . * They will be able to understand orders given to them.

Exclusion criteria

* Subjects will be excluded if they have the following: 1. Visual or hearing impairment. 2. Severe limb deformities as structural genurecurvatum. 3. Surgical interference in the lower limbs for the last 6 months. 4. Botulinum toxin injection of the spastic lower limb muscles during the last six months.

Design outcomes

Primary

MeasureTime frameDescription
degree of genu recurvatum10 minutesdegree of genu recurvatum will be measured by Radiological X-Ray

Secondary

MeasureTime frameDescription
muscle power2 minutesmuscle power will be assessed by using Lafayette Manual Muscle Tester
balance20 minutesBalance will be assessed by Pediatric Balance Scale
functional mobility20 minutesFunctional mobility will be assessed by Mobility Questionnaire (Mob Quest 28 )
Quality of child life20 minutes administration for each childQuality of life will be assessed by using Pediatric Quality of Life Inventory (PedsQL) scale

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026